The area of pharmaceutical patents is highly complex with many pitfalls to be aware of and to know how to mitigate against. During this course the expert faculty will take you through the key differences between the European and US systems and how these can impact your patents. They will explore the latest strategies and give you useful insights and practical solutions to your drafting issues. By understanding the importance of aligning your patent and regulatory strategies, you will improve your pharmaceutical claim drafting skills to the best advantage.
The practical claim drafting exercises included in the course will give you an opportunity to get to grips with the information in a safe environment and under the guidance of the expert trainers. They will help embed what you have learnt so that it can be taken back to the workplace and put into practice.
As well as receiving inside knowledge and top tips and advice from the highly experienced speaker, the course also provides a valuable opportunity to network with others in similar roles from different companies. By attending, you can discuss your challenges with colleagues and our expert faculty and find solutions to your questions.
Key topics covered in this intensive training programme include:
- Drafting primary patents and secondary patents
- Key differences between drafting for Europe versus the US
- Claim drafting strategies for antibodies and other biologics
- Drafting claims that ‘follow the label’
- Drafting patent applications with sufficient supporting data - how much is enough?
- Aligning your patent strategy with regulatory issues
Benefits of attending
By attending this course you will:
- Understand how to draft primary patents in the small molecule and biologics fields
- Ensure comprehensive protection for innovations from genetic sequences through to therapeutic applications
- Learn how to protect medical use claims - first, second and Swiss-type
- Get to grips with drafting claims for infringement
- Consider regulatory issues and data protection
- Enhance your knowledge of the data needed to support patent applications
- Recognise the importance of correct data in avoiding inequitable conduct
- Boost your knowledge of secondary patents and their benefits
Certifications:
- CPD: 12 hours for your records
- Certificate of completion
Speakers
Amanda Murphy,
Partner ,
Finnegan’s Washington, DC OfficeDr. Amanda Murphy is a Partner in Finnegan’s Washington, DC Office and focuses her practice on strategic client counseling, portfolio management, and patent prosecution for a range of clients, including small startup companies, research foundations, and large biotechnology and pharmaceutical companies.
Amanda provides patentability opinions, prepares new patent applications, prosecutes U.S. and foreign applications, and represents appellants before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). She has experience in prosecuting inter partes and ex parte reexamination applications, reissue applications, and patent term extension applications for approved pharmaceuticals, including obtaining supplemental protection certificates in Europe. In addition to her patent counseling and prosecution practice, Amanda also routinely represents petitioners and patent owners in inter partes review (IPR) and post grant review (PGR) proceedings before the PTAB. As part of that practice, Amanda works with experts to develop technical and legal bases for challenging or defending issued patents, and manages the preparation of substantive written submissions. She also provides strategic advice and pre-litigation analysis and prepares freedom-to-operate, enforceability, and infringement opinions.
Who Should Attend
This course has been specially designed for:
- Patent attorneys
- In-house lawyers
- Private practice lawyers
- Patent agents and consultants
